ArticleJMIR aging2026
Development and Temporal External Validation of a Parsimonious, Interpretable Machine Learning Model for Predicting 6-Month Mortality in Long-Term Care Facilities: A Retrospective Cohort Study.
Article in JMIR aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early mortality after long-term care facility (LTCF) admission is common; yet, prognostic tools are often derived from Western minimum dataset-based cohorts or require hospital electronic health record linkages that are unavailable at intake in many LTCFs. There is also limited evidence on explainable, admission-feasible machine learning-based prognostication in Asian LTCF settings. Objective: The aim of the study is to develop and temporally externally validate an interpretable machine learning model for predicting 6-month all-cause mortality among older adults newly admitted to LTCFs in Taiwan using routinely collected LTCF assessment data. Methods: We conducted a retrospective cohort study using the JUBO Long-Term Care Database, a nationwide private administrative registry covering 636 LTCFs (37.4% of the national LTCFs) in Taiwan. We included residents with first-time LTCF admission and prespecified nonoverlapping cohorts for temporal validation: development (January 1, 2020, to December 31, 2023; n=23,901) and external validation (January 1 to December 31, 2024; n=6216). The outcome measure was death within 180 days of admission. We compared a nonlinear ensemble model (hybrid of extreme gradient boosting and random forest [HybridXGBRF]) with 7 other algorithms, including tree-based and linear benchmarks. Discrimination (area under the receiver operating characteristic curve [AUROC]), classification metrics (accuracy, precision, recall, and Results: In the development cohort, 5272 of 23,901 (22.1%) residents died within 180 days. In the 2024 temporal validation cohort, 1781 of 6216 (28.7%) residents died. In internal cross-validation, HybridXGBRF had the highest AUROC among the evaluated models (0.89, 95% CI 0.88-0.89). In temporal validation, HybridXGBRF maintained strong discrimination (AUROC 0.90, 95% CI 0.89-0.91), with an accuracy of 0.85 and an Conclusions: An interpretable machine learning model using routinely collected Taiwanese LTCF assessment data achieved strong discrimination, acceptable calibration, and stable temporal validation performance without requiring hospital-based electronic health record linkage. The HybridXGBRF had the highest AUROC among the evaluated models, but performance differences from extreme gradient boosting were small. The model may serve as a risk-stratification tool to help identify residents who could benefit from structured care review, advance care planning, or palliative care assessment. Prospective implementation studies could determine its impact on care processes and resident- or family-centered outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.